IW | Novel Anti-Seizure Mechanistic Targets of Metabolic Substrates

Sunday, December 6, 2026 at 10:30 AM to 12:00 PM · 1 hr. 30 min. (America/Denver)
Investigators Workshop

Information

Metabolic therapies have re-emerged as potentially powerful anti-seizure interventions, yet their underlying mechanisms remain incompletely defined. This Investigators’ Workshop explores how metabolic substrates, such as 2-deoxy-D-glucose, β-hydroxybutyrate, and adenosine, act as signaling molecules to regulate neuronal excitability and neuroinflammation. Through short presentations and a moderated discussion, presenters examine receptor-mediated pathways, stereochemical specificity, immune-metabolic interactions, and opportunities for combining metabolic strategies. Emphasis is placed on unresolved questions and future directions that are guiding the development of mechanism-based metabolic therapies for epilepsy and its prevention.
Learning Objective 1
Evaluate emerging metabolic signaling pathways, including 2-deoxy-D-glucose, β-hydroxybutyrate, and adenosine, as mechanistic regulators of neuronal excitability and seizure dynamics
Learning Objective 2
Compare neuronal and glial mechanisms by which metabolic substrates suppress seizures
Learning Objective 3
Identify unresolved mechanistic questions and translational opportunities for integrating metabolism-based strategies into anti-seizure therapies
Career Stage
Early Career (typically 0-5 years from completion of training)Mid-Career (typically 6-15 years from completion of trainingSenior (typically >15 years from completion of training)
Session ID
NOVELIW26
Presentation Id
3451963
Event ID
24056
Session Type
Session